PLATFORM Combined solutions for patientsOctober 2015 Zurich, Switzerland

First Page		Document Content
Date: 2015-10-12 05:42:17 Novartis Medtech UBS Hoffmann-La Roche		PLATFORM Combined solutions for patientsOctober 2015 Zurich, Switzerland Add to Reading List Source URL: www.medtech-pharma.com Download Document from Source Website File Size: 1,42 MB Share Document on Facebook

	TAMIFLU - oseltamivir phosphate powder, for suspension TAMIFLU - oseltamivir phosphate capsule Hoffmann-La Roche Inc DESCRIPTION TAMIFLU (oseltamivir phosphate) is available DocID: 1v09s - View Document
	Panel II: SMA Drugs in Development • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Lawrence Charnas, MD, PhD, Sr. Translational Medicine Expert, Musculoskeletal Diseases, Novart DocID: 1sY97 - View Document
	Panel II: SMA Drugs in Development • Jinsy Andrews MD, Director of Clinical Research and Development, Cytokinetics • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Jerry R. Men DocID: 1sY50 - View Document
	FERCAP Conference Empowering Stakeholders in Health Research: Towards Developing an Ethics of Accountability and Responsibility Beat Widler, F. Hoffmann-La Roche Bangkok , Thailand DocID: 1sI6G - View Document
	orlistat and pcoc orlistat 60 mg studies persistence analysis sibutramine orlistat, clinical studies orlistat, orlistat and gall stones does orlistat work, health problems and orlistat orlistat and appetite. orlistat pre DocID: 1rrCO - View Document